Industry
Biopharmaceuticals
Challenge
An extensive cataloging and inventory of the facility's equipment was vital to achieving our client’s objectives of asset visibility, effectively redistributing equipment across their various business units, and sustainably liquidating surplus equipment and assets. The entire project demanded precision, operational adeptness, and strict timeline adherence
Results
Over 400 assets were effectively redistributed to the client's New Jersey, Massachusetts, Pennsylvania, and California facilities during this project, with close to $630,000 in gross sales generated through the compliant external sale
Background
Our client, a prominent American multinational pharmaceutical company, has been engaged in a decadelong partnership with Liquidity Services. This collaboration involves monthly sales of surplus assets as the company's requirements evolve. Following a recent acquisition, Liquidity Services was enlisted to navigate the challenges of identifying, creating enterprise-wide visibility, and then redistributing surplus assets.
The Challenge
The acquisition involved a substantial inventory of the physical assets of the acquired entity's Boston-area campus. An extensive cataloging and inventory of the facility's equipment was vital to achieving our client’s objectives of asset visibility, effectively redistributing equipment across their various business units, and sustainably liquidating surplus equipment and assets. The entire project demanded precision, operational adeptness, and strict timeline adherence.
|
Key Client Factors
|
The Solution
Liquidity Services' solution included detailed cataloging of assets, strategic redeployment, and a sustainable liquidation through Liquidity Services' online marketplace, AllSurplus.com. This approach met the client's immediate needs and resulted in approximately $3 million in CapEx savings, efficiently filling resource gaps across the organization. Over 400 assets were effectively redistributed to the client's New Jersey, Massachusetts, Pennsylvania, and California facilities during this project, with close to $630,000 in gross sales generated through the compliant external sale. This contributed to a 30% increase in the annual average of recovered working capital from ongoing surplus, adding to the over $22 million in sales generated during the client's ten-year partnership with Liquidity Services.
Leveraging its established platform and experienced operations team, Liquidity Services played a critical role in our client’s efficient optimization of the acquired assets which maximized benefits of their acquisition.
This project emphasizes the advantages of a long-term partnership and highlights Liquidity Services' success in managing large-scale and complex projects.
| Sale Items of Note | ||
 |
 |
 |
| Cytiva/ GE Healthcare Biosciences Chromatograph HPLC | Carl Zeiss Observer Z1 Laser Scanning Microscope | Sakura FinetekTissue Tek GlasG2 A1 Cover Slipping Machine |
